Description
Recombinant monoclonal antibody to CD22. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma RFB-4.
Target
CD22
Target Alias Names
SIGLEC-2, SIGLEC2
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression